Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Giles

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of the American Society of Hypertension : JASH|April 13, 2011
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroupsElizabeth O Ofili, Suzanne Oparil, Thomas Giles, et al.
The Journal of Trauma and Acute Care Surgery|July 8, 2022
Acute kidney injury development in polytrauma and the safety of early repeated contrast studies: A retrospective cohort studyThomas Giles, Natasha Weaver, Adrian Varghese, et al.
American Journal of Clinical Pathology|May 17, 2011
The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification systemGabrijela Kocjan, Ashish Chandra, Paul A Cross, et al.
Neurourology and Urodynamics|July 4, 2025
Diagnostic and Therapeutic Outcomes of Ambulatory Urodynamics in a Tertiary Referral CenterCharlotte Mary Hughes, Nikita Rajiv Bhatt, Johanna Catherine Georgina Penfold, et al.
International Journal of Oncology|November 24, 2011
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspiratesDimo Dietrich, Christoph Kneip, Olaide Raji, et al.
Circulation. Heart Failure|February 8, 2013
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research studyYee Weng Wong, Laine Thomas, Jie-Lena Sun, et al.
BMJ (Clinical Research Ed.)|February 8, 2019
Primary cervical screening with high risk human papillomavirus testing: observational studyMatejka Rebolj, Janet Rimmer, Karin Denton, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndromeAndrew J Drexler, Richard W Nesto, Martin J Abrahamson, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the American Society of Hypertension : JASH|April 13, 2011
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroupsElizabeth O Ofili, Suzanne Oparil, Thomas Giles, et al.
The Journal of Trauma and Acute Care Surgery|July 8, 2022
Acute kidney injury development in polytrauma and the safety of early repeated contrast studies: A retrospective cohort studyThomas Giles, Natasha Weaver, Adrian Varghese, et al.
American Journal of Clinical Pathology|May 17, 2011
The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification systemGabrijela Kocjan, Ashish Chandra, Paul A Cross, et al.
Neurourology and Urodynamics|July 4, 2025
Diagnostic and Therapeutic Outcomes of Ambulatory Urodynamics in a Tertiary Referral CenterCharlotte Mary Hughes, Nikita Rajiv Bhatt, Johanna Catherine Georgina Penfold, et al.
International Journal of Oncology|November 24, 2011
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspiratesDimo Dietrich, Christoph Kneip, Olaide Raji, et al.
Circulation. Heart Failure|February 8, 2013
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research studyYee Weng Wong, Laine Thomas, Jie-Lena Sun, et al.
BMJ (Clinical Research Ed.)|February 8, 2019
Primary cervical screening with high risk human papillomavirus testing: observational studyMatejka Rebolj, Janet Rimmer, Karin Denton, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndromeAndrew J Drexler, Richard W Nesto, Martin J Abrahamson, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
Pageof 3